Important news from Latanya

Shares of the company fell about 16 percent to $2.95 in pre-market trade. They closed at $3.50 on Thursday on Nasdaq.On Aug. 1, the company said the FDA placed a hold on two late-stage trials for the drug, in cystic fibrosis patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.FDA now requires the company to conduct a mid-stage study in adult NTM patients to provide efficacy and safety data, and to further revise the assessment of a rat carcinogenicity study findings.”Now that we have responses from the FDA with respect to both clinical holds, we are seeking further inputs from the agency in order to gain a better understanding of their requests regarding CF and NTM,” Chief Executive Timothy Whitten said in a statement.

Last August, Rogers, which operates in the island’s financial, property, hotel, aviation and logistics sectors — said profit before tax rose to 439.6 million rupees for the nine months to end-June.Mauritius is famed for its white sandy beaches and spas catering to the luxury end of the leisure market.According to Swan Group’s website, it operates as Swan Insurance Co Ltd for short-term insurance business and as Anglo-Mauritius Assurance Society Ltd for life assurance, pensions, actuarial and investment business.